Schütte J - Search Results

1

Bombesin antagonists: experimental and clinical results.

Schütte J, Seeber S. Schütte J, et al. Recent Results Cancer Res. 1993;129:115-29. doi: 10.1007/978-3-642-84956-5_9. Recent Results Cancer Res. 1993. PMID: 7688906 Review. No abstract available.

2

Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.

Bauer S, Hagen V, Pielken HJ, Bojko P, Seeber S, Schütte J. Bauer S, et al. Among authors: schutte j. Anticancer Drugs. 2002 Sep;13(8):847-9. doi: 10.1097/00001813-200209000-00010. Anticancer Drugs. 2002. PMID: 12394270

3

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B. Werner NS, et al. Among authors: schutte j. Cancer Res. 2000 Jun 1;60(11):2780-5. Cancer Res. 2000. PMID: 10850413

4

Gemcitabine in the treatment of soft tissue sarcomas.

Bauer S, Seeber S, Schütte J. Bauer S, et al. Among authors: schutte j. Onkologie. 2004 Apr;27(2):180-6. doi: 10.1159/000076910. Onkologie. 2004. PMID: 15138353 Review.

5

[Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].

Schütte J, Niederle N, Eberhardt W, Seeber S, Alberti W, Budach V, Hirche H, Schmidt CG. Schütte J, et al. Klin Wochenschr. 1989 Dec 4;67(23):1182-93. doi: 10.1007/BF01716205. Klin Wochenschr. 1989. PMID: 2558254 Clinical Trial. German.

6

Novel tumor suppressor locus in human chromosome region 3p14.2.

Jülicher K, Marquitan G, Werner N, Bardenheuer W, Vieten L, Bröcker F, Topal H, Seeber S, Opalka B, Schütte J. Jülicher K, et al. Among authors: schutte j. J Natl Cancer Inst. 1999 Sep 15;91(18):1563-8. doi: 10.1093/jnci/91.18.1563. J Natl Cancer Inst. 1999. PMID: 10491433

7

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schütte J. Bauer S, et al. Among authors: schutte j. Int J Cancer. 2005 Nov 1;117(2):316-25. doi: 10.1002/ijc.21164. Int J Cancer. 2005. PMID: 15900603 Clinical Trial.

8

Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.

Schütte J, Kellner R, Seeber S. Schütte J, et al. Cancer Chemother Pharmacol. 1993;31 Suppl 2:S194-8. Cancer Chemother Pharmacol. 1993. PMID: 8453697

9

Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinoma.

Willers CP, Siebert R, Bardenheuer W, Lux A, Michaelis S, Seeber S, Luboldt HJ, Opalka B, Schütte J. Willers CP, et al. Among authors: schutte j. Br J Urol. 1996 Apr;77(4):524-9. doi: 10.1046/j.1464-410x.1996.09287.x. Br J Urol. 1996. PMID: 8777611

10

Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.

Schröder JK, Kirch C, Flasshove M, Kalweit H, Seidelmann M, Hilger R, Seeber S, Schütte J. Schröder JK, et al. Among authors: schutte j. Leukemia. 1996 Dec;10(12):1919-24. Leukemia. 1996. PMID: 8946931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters